Eagle Pharmaceuticals, Inc.

CITIGROUP INC EGRX

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/12/2024

Shares

1,000,389

Value ($000)

3,731

Weight

0.0%

2019 Q4 - 2024 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/12/2024	3,731	0.0%	1,000,389	9/30/2024
2024 Q2	8/12/2024	5,609	0.0%	1,001,555	6/30/2024
2024 Q1	5/10/2024	14	0.0%	2,718	3/31/2024
2023 Q4	2/9/2024	9	0.0%	1,746	12/31/2023
2023 Q3	12/6/2023	3	0.0%	203	9/30/2023
2023 Q2	8/10/2023	117	0.0%	6,037	6/30/2023
2023 Q1	5/11/2023	210	0.0%	7,412	3/31/2023
2022 Q4	2/9/2023	987	0.0%	33,778	12/31/2022
2022 Q3	11/10/2022	1,543	0.0%	58,391	9/30/2022
2022 Q2	8/10/2022	1,212	0.0%	27,278	6/30/2022
2022 Q1	5/12/2022	797	0.0%	16,106	3/31/2022
2021 Q4	2/10/2022	1,823	0.0%	35,796	12/31/2021
2021 Q3	11/10/2021	1,186	0.0%	21,257	9/30/2021
2021 Q2	8/10/2021	1,813	0.0%	42,362	6/30/2021
2021 Q1	5/13/2021	1,782	0.0%	42,699	3/31/2021
2020 Q4	2/11/2021	340	0.0%	7,305	12/31/2020
2020 Q3	11/12/2020	312	0.0%	7,344	9/30/2020
2020 Q2	8/12/2020	826	0.0%	17,223	6/30/2020
2020 Q1	5/12/2020	610	0.0%	13,268	3/31/2020
2019 Q4	2/12/2020	457	0.0%	7,609	12/31/2019